Reported Reactions

Devices › Device types

FDA product code MEG · class 2 · General Hospital

Syringe, antistick: medical device reports filed with FDA

2,952 reports carry this product code, 2000–2026; 12 brands with a page.

2,952
reports with this product code
0% of all MAUDE reports
96
reports, 12 months to August 2026
177 in the 12 months before
88.1%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

Product code MEG is FDA's classification for "Syringe, antistick" (general Hospital panel), a class 2 device. 2,952 medical device reports carry this product code, 0% of the MAUDE database, from February 2000 to August 2026.

96 reports arrived in the 12 months to August 2026, down 46% from 177 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88.1%), injury (8.7%) and other (2%). 12 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Bd Integra Syringe With Detachable Needle24700%83.1%
VanishPoint15390%95.7%
Sol-Millennium5650%100%
BD SafetyGlide421270%98.4%
Bd Insulin Syringe With The Bd Ultra-Fine Needle600%97.5%
Jelco4340%84.3%
Monoject3140.2%88.4%
Bd Precisionglide Needle200%95.9%
Magellan2200%95.2%
Portex280.6%80.6%
Bd Insulin Syringes With Bd Ultra-Fine Needle100%99.2%
Spectrum Infusion Pump1150%99.7%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Becton Dickinson Medical Systems64221.7%
Bd Medical - Diabetes Care2869.7%
Becton Dickinson672.3%
Bd Medical Bd West Medical Surgical331.1%
Bd190.6%
Becton Dickinson And190.6%
Terumo Medical80.3%
Smiths Medical60.2%
Mhc Medical Products40.1%
Becton Dickinson Ind Cirurgicas Ltda20.1%
Becton Dickinson Infusion Therapy Systems20.1%
Becton Dickinson & Bd10%

Reports by month, five years

02243Sep 2021: 20Oct 2021: 17Nov 2021: 30Dec 2021: 222022Jan 2022: 15Feb 2022: 10Mar 2022: 7Apr 2022: 23May 2022: 13Jun 2022: 18Jul 2022: 13Aug 2022: 12Sep 2022: 12Oct 2022: 23Nov 2022: 18Dec 2022: 62023Jan 2023: 2Feb 2023: 5Mar 2023: 23Apr 2023: 9May 2023: 9Jun 2023: 11Jul 2023: 12Aug 2023: 11Sep 2023: 13Oct 2023: 11Nov 2023: 10Dec 2023: 42024Jan 2024: 11Feb 2024: 7Mar 2024: 5Apr 2024: 4May 2024: 6Jun 2024: 6Jul 2024: 7Aug 2024: 11Sep 2024: 12Oct 2024: 13Nov 2024: 15Dec 2024: 152025Jan 2025: 12Feb 2025: 0Mar 2025: 12Apr 2025: 9May 2025: 43Jun 2025: 26Jul 2025: 15Aug 2025: 5Sep 2025: 3Oct 2025: 7Nov 2025: 6Dec 2025: 102026Jan 2026: 16Feb 2026: 7Mar 2026: 11Apr 2026: 6May 2026: 2Jun 2026: 15Jul 2026: 2Aug 2026: 11

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death0%0
Injury8.7%258
Malfunction88.1%2,600
Other2%58
Not given1.2%36

Who filed

Manufacturer report80.6%2,380
Voluntary report11.1%329
User facility report0%0
Distributor report0%1
Not given8.2%242

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Leak/splashthe device leaked52117.6%
Breakthe device broke38713.1%
Difficult or delayed activation35211.9%
Retraction problem31410.6%
Fluid/blood leak1143.9%
Detachment of device component1013.4%
Detachment of device or device componentpart of the device came off933.2%
Fail-safe problem903%
Device contamination with chemical or other material752.5%
Failure to deliverthe device did not deliver the dose or item682.3%
Activation problem672.3%
Defective devicethe device was defective662.2%
Activation failure561.9%
Device operates differently than expectedthe device behaved unexpectedly541.8%
Defective component501.7%
Device contaminated during manufacture or shipping461.6%
Material protrusion/extrusion461.6%
Device markings/labelling problema problem with the device markings or label371.3%
Material twisted/bent351.2%
Bent341.2%

Questions about syringe, antistick reports

What is product code MEG?

FDA's classification code for "Syringe, antistick", class 2, reviewed by the general Hospital panel. Every device report carries the product code of the device involved.

How many reports carry this code?

2,952 reports through August 2026, 96 of them in the latest 12 months.

Which brands appear most often?

Bd Integra Syringe With Detachable Needle (247), VanishPoint (153), Sol-Millennium (56), BD SafetyGlide (42) and Bd Insulin Syringe With The Bd Ultra-Fine Needle (6). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.